MNX1-AS1 and breast cancer: In a murine xenograft model of bone metastasis (with both breast cancer or lung cancer cells) MAYA knockdown reduced bone metastasis burden suggesting that targeting MAYA is a possible strategy to impair bone metastasis development (85).